TMC
MRTX

Trellus Management Company’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Trellus Management Company’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,524
Closed -$503K – 67
2023
Q1 		$503K Buy
13,524
+6,886
+104% +$256K 0.59% 30
2022
Q4 		$301K Buy
+6,638
New +$301K 0.38% 39